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Abstract
Background: The association between Institute of Medicine (IOM) guidelines and pregnancy outcomes across
ethnicities is uncertain. We evaluated the associations of gestational weight gain (GWG) outside 2009 IOM
guidelines, with maternal and infant outcomes across the USA, western Europe and east Asia, with subgroup
analyses in Asia. The aim was to explore ethnic differences in maternal prepregnancy body mass index (BMI), GWG
and health outcomes across these regions.
Methods: Systematic review, meta-analysis and meta-regression of observational studies were used for the study.
MEDLINE, MEDLINE In-Process, Embase and all Evidence-Based Medicine (EBM) Reviews were searched from 1999 to
2017. Studies were stratified by prepregnancy BMI category and total pregnancy GWG. Odds ratio (ORs) 95%
confidence intervals (CI) applied recommended GWG within each BMI category as the reference. Primary outcomes
were small for gestational age (SGA), preterm birth and large for gestational age (LGA). Secondary outcomes were
macrosomia, caesarean section and gestational diabetes.
Results: Overall, 5874 studies were identified and 23 were included (n = 1,309,136). Prepregnancy overweight/
obesity in the USA, Europe and Asia was measured at 42%, 30% and 10% respectively, with underweight 5%, 3%
and 17%. GWG below guidelines in the USA, Europe and Asia was 21%, 18% and 31%, and above was 51%, 51%
and 37% respectively. Applying regional BMI categories in Asia showed GWG above guidelines (51%) was similar to
that in the USA and Europe.
GWG below guidelines was associated with a higher risk of SGA (USA/Europe [OR 1.51; CI 1.39, 1.63]; Asia [1.63; 1.45, 1.82])
and preterm birth (USA/Europe [1.35; 1.17, 1.56]; Asia [1.06; 0.78, 1.44]) than GWG within guidelines. GWG above guidelines
was associated with a higher risk of LGA (USA/Europe [1.93; 1.81, 2.06]; Asia [1.68; 1.51 , 1.87]), macrosomia (USA/Europe
[1.87; 1.70, 2.06]; Asia [2.18; 1.91, 2.49]) and caesarean (USA/Europe [1.26; 1.21, 1.33]; Asia [1.37; 1.30, 1.45]). Risks remained
elevated when regional BMI categories were applied for GWG recommendations. More women in Asia were categorised
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as having GWG below guidelines using World Health Organization (WHO) (60%) compared to regional BMI categories
(16%), yet WHO BMI was not accompanied by increased risks of adverse outcomes.
Conclusions: Women in the USA and western Europe have higher prepregnancy BMI and higher rates of GWG above
guidelines than women in east Asia. However, when using regional BMI categories in east Asia, rates of GWG above
guidelines are similar across the three continents. GWG outside guidelines is associated with adverse outcomes across
all regions. If regional BMI categories are used in east Asia, IOM guidelines are applicable in the USA, western Europe
and east Asia.
Keywords: Pregnancy, Ggestational weight gain, Maternal and infant outcomes, Obesity, Small for gestational age,
Large for gestational age, Gestational diabetes, Caesarean section, Macrosomia, Preterm birth
Background
Gestational weight gain (GWG) is influenced by many
factors including the obesogenic environment, prepreg-
nancy body mass index (BMI), age, parity, smoking,
socioeconomic status and comorbid medical conditions
[1, 2]. Excess or insufficient GWG is associated with
higher risks of adverse pregnancy outcomes, including
preterm birth, macrosomia and caesarean delivery [3].
The US Institute of Medicine (IOM) developed GWG
guidelines in 1990 and updated them in 2009 (Table 1),
yet nearly three quarters of women now gain weight out-
side these guidelines [4, 5]. Given that lifestyle interven-
tion improves outcomes, meeting GWG guidelines is an
important target [6]. However, the IOM guidelines are
based on data from primarily USA-dwelling, Caucasian
and Black women, with limited ethnic diversity that may
not be applicable to women from Europe and Asia.
Given that Asia is the most populous continent, inhab-
ited by 60% of the world’s population, applicability of
GWG guidelines to Asian populations is an international
public health priority.
At lower BMI, people from Asia have a greater risk for
cardiovascular disease and diabetes [7, 8] than Caucasians,
with a higher body fat percentage and greater central
obesity [9]. During pregnancy, women from Asian coun-
tries have different risk profiles than Caucasian women.
Asian-American women have a higher risk of gestational
diabetes mellitus (GDM), caesarean section and low birth-
weight babies, and a lower risk of gestational hypertension
and macrosomia compared to non-Hispanic white women
[10]. Amongst Asian women, Korean and Taiwanese
women have greater GWG and postpartum weight reten-
tion than women from other Asian countries [11]. In this
context, GWG guidelines in Asian women may need to be
considered differently; however, there is insufficient com-
parative research to date.
The 2009 IOM guidelines, although based on limited
data, showed no ethnic differences in associations between
GWG and pregnancy outcomes, whilst calling for further
research [4]. Currently, there are no specific GWG guide-
lines for women from Asia. Most Asian studies use
Caucasian-derived IOM GWG guidelines, and some use
their own regional guidelines [12]. This creates heterogen-
eity and limits comparisons across regions, underpinning
calls for new ethnic-specific regional GWG guidelines in
China [13], highlighting gaps in current guidelines.
In this systematic review, meta-analysis and
meta-regression, we aimed to explore ethnic differences
in maternal prepregnancy BMI, GWG and health out-
comes across the USA, Europe and Asia. In Asia, we
also aimed to explore GWG and health outcomes using
ethnic-specific regional BMI and World Health
Organization (WHO) BMI categories.
Methods
This systematic review and meta-analysis was conducted
according to the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) protocol.
This protocol was registered with the PROSPERO Inter-
national Prospective Register of Systematic reviews
(registration number CRD42015023325). An analysis of
all pooled data is published [5]. This study focused on
ethnic differences in maternal BMI, GWG and maternal
and neonatal outcomes.
The methods used for study eligibility, data extraction
and risk of bias have been detailed previously [5] (search
Table 1 2009 IOM Recommendations for gestational weight gain during pregnancy
Recommendations Underweight Normal weight Overweight Obese
Prepregnancy BMI (kg/m2) < 18.5 18.5–24.9 25.0–29.9 ≥30
Total weight gain range (kg) 12.5–18 11.5–16 7–11.5 5–9
Total weight gain range (lbs) 28–40 25–35 15–24 11–20
Adapted from 2009 IOM guidelines
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terms and search strategy are discussed in Additional
files 1 and 2). Briefly, observational studies published in
the English language between January 1999 and February
2017, with a sample size of more than 500 women were
included. Studies assessing multiple pregnancies and
pregnancies in women < 18 years were excluded. Inclu-
sion required that studies present data examining the
women by prepregnancy BMI category (underweight,
normal weight, overweight, obese), stratified by the total
pregnancy GWG (studies using weekly GWG were ex-
cluded). The odds ratio (OR) for each outcome had to
be stratified by maternal BMI and GWG. Papers that
mutually adjusted for BMI and GWG were excluded.
After identifying wide variations in prepregnancy BMI
and GWG categories, meaningful interpretation and
meta-analysis were not possible. Relevant authors were
contacted to reanalyse and present data using consist-
ent categories. Chinese and Korean studies used
ethnic-specific BMI categories (China: underweight
BMI < 18.5 kg/m2, normal weight 18.5–23.9 kg/m2,
overweight 24–28 kg/m2 and obese ≥ 28 kg/m2;
Korea: underweight BMI < 18.5 kg/m2, normal weight
18.5–22.9 kg/m2, overweight 23–25 kg/m2 and obese
≥ 25 kg/m2) whilst Japanese and Taiwanese studies
used WHO BMI categories (underweight < 18.5 kg/m2,
normal weight 18.5–24.9 kg/m2, overweight 25–
29.9 kg/m2 and obese ≥30 kg/m2).
Primary outcomes were (1) small for gestational age
(SGA): < 10th percentile of birthweight for sex and gesta-
tional age, (2) pre-term birth: spontaneous birth < 37 weeks
gestation, (3) large for gestational age (LGA): > 90th per-
centile of birthweight for sex and gestational age. Second-
ary outcomes were (1) macrosomia: birthweight > 4000 g,
(2) caesarean section and (3) GDM.
Strategy for data synthesis
Study findings were synthesised based on target popula-
tion characteristics, type of study and outcome. Propor-
tions were calculated using the pooled number in a group
divided by the total number (%). The chi-squared test was
used to assess difference in proportion of women within
BMI categories and GWG categories between regions.
The two-sample test of proportions was used to assess dif-
ferences between two particular regions.
Summaries of outcomes associated with GWG were
produced for each study by calculating the ORs and 95%
confidence intervals (CIs), using the recommended
GWG within each BMI category as the reference. Where
two or more studies assessed the same outcome, the re-
sults were pooled using random-effects meta-analysis,
calculating the OR and 95% CI for each outcome. Ex-
tracted pooled ORs for each outcome were combined to
construct a summary pooled OR for all outcomes. Crude
data was used where possible given the variation in
control for confounding factors. However, some papers
presented adjusted ORs only [14–21]. US and European
studies were combined as one group in the
meta-analysis of pregnancy outcomes (to allow for two
or more studies to assess each outcome) and compared
to Asian studies. We were unable to demonstrate statis-
tical significance for comparison of ORs for SGA, pre-
term birth, LGA, macrosomia and caesarean section
between the US/Europe and Asian studies due to similar
ORs and overlap in CIs.
Heterogeneity was assessed using the I2 statistic. An I2
value greater than 50% was indicative of substantial het-
erogeneity [22] . Where there was sufficient data avail-
able, a meta-regression analysis was performed to
investigate sources of heterogeneity, including percent-
age of smokers in pregnancy, mean age and percentage
nulliparity. Sufficient data on race/ethnicity was not
available for inclusion in the meta-regression. Studies
from Europe and Asia did not provide information re-
garding race or ethnicity. Studies from the USA provided
race/ethnicity data; however, this varied with reporting
methods (some report percentage of total population,
others report percentage stratified by GWG).
A further analysis of women living in Asian countries
was performed comparing studies using regional BMI cat-
egories (Chinese and Korean studies) and WHO BMI cat-
egories (Japanese and Taiwanese) assessing alignment
with 2009 IOM GWG guidelines and maternal and infant
adverse outcomes. Statistical analysis used Stata software
v.14 and was supported by a biostatistician (SR).
Results
From 5874 studies identified by the initial search, 302
studies were selected for full text review (Fig. 1) and 261
studies were excluded, using a priori selection criteria.
Forty papers grouped women by prepregnancy BMI cat-
egory (underweight, normal weight, overweight, obese),
stratified by the total GWG for the pregnancy. One
study [23] did not initially meet inclusion criteria be-
cause ORs were not stratified by both BMI and GWG.
However, through collaborations, this data was available
in the required format. Where required, authors were
contacted for data reanalysis, and 13 collaborated
(Additional file 2).
In total, 23 cohort studies [12, 14–21, 23–36] were in-
cluded in this systematic review and meta-analysis, report-
ing data on more than 1 million women (n = 1,309,136).
Study characteristics
Table 2 describes the study design and size, eligibility cri-
teria and outcomes (descriptive characteristics are shown
in Additional file 3: Table S1). Eighteen studies were retro-
spective, five were prospective [14, 25, 28, 31, 36]. Ten
studies were from the USA [14, 17, 18, 20, 23, 27, 29, 30,
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32, 33], five from western Europe (one each from Norway
[25], Belgium [35], Italy [24], Denmark [28] and Sweden
[15]) and eight from east Asia (four from China [16, 26,
31, 36], two from Korea [12, 34], one each from Taiwan
[21] and Japan [19]). The sample size ranged from 1034 to
570,672.
Overall, 66% (n = 865,790) of women were from the
USA, 10% (n = 125,203) from Western Europe and 24%
(n = 318,143) from east Asia.
Analysis by region: USA, Europe and Asia
In the descriptive analysis of maternal BMI only, it was
required to exclude two European studies [15, 35] (52%
of European women) and four US studies [18, 20, 30,
32] (3% of US women) which studied obese women
only, and one Asian study [16] (4% of Asian women)
which studied normal weight women only. In the
remaining studies, overweight and obesity were present
in 43% of women in the USA, 31% in Europe and 10%
in Asia (Table 3). Underweight BMI was present in 5%
in the USA, 3% in Europe and 17% in Asia. The propor-
tion of women within each BMI category was different
between the regions (p < 0.0001) (using the chi-squared
test).
Overall, underweight women had the greatest preva-
lence of GWG below guidelines (43%), whereas over-
weight women, followed by obese women, had the
greatest prevalence of GWG above guidelines (64% and
60% respectively) (Table 4).
For GWG below guidelines, prevalence was 21%, 18%
and 31% in the USA, Europe and Asia respectively, includ-
ing all Asian data (Table 5). The proportion of women
gaining below guidelines was different between the three
regions (p < 0.0001) (using the chi-squared test).
Fig. 1 Flow Diagram of study selection process
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Table 2 Characteristics of 23 included studies
Study Country Study period Study design Sample size Setting Outcomes
Durst,
2016 [20]
USA 2000–2014 Retrospective 5651 University of Alabama,
Birmingham
SGA, LGA, macrosomia,
caesarean section
Enomoto,
2016 [19]
Japan 2013 Retrospective 97,157 Japan Society of Obstetrics and
Gynaecology Registry system
with 280 participating hospitals
SGA, preterm birth, LGA,
macrosomia, caesarean
Hung,
2016 [21]
Taiwan 2009–2015 Retrospective 10,973 Taipei Chang Gung
Memorial Hospital
SGA, LGA, macrosomia, caesarean section
Xionge,
2016 [36]
China 2012–2013 Prospective 57,891 Hospitals and community centres Caesarean section
Bogaerts,
2015 [35]
Belgium 2009–2011 Retrospective 18,053 Flemish study center for perinatal Caesarean section, macrosomia, LGA
Shin,
2015 [33]
USA 2004–2011 Retrospective 219,868 Pregnancy risk assessment
monitoring system (PRAMS)
Preterm birth, SGA, LGA
Wene,
2015 [16]
China 2009–2013 Retrospective 13,776 Jishuitan Hospital Preterm birth
Yange,
2015 [31]
China 2011–2013 Prospective 85,765 Wuhan Women and Children
Health Care Center
Macrosomia
Badon,
2014 [14]
USA 2000–2006 Prospective 5297 North American Field Centers,
HAPO
LGA
Chihara,
2014 [17]
USA 2003–2005 Retrospective 19,130 Hawaii’s special supplemental
program for women, infants
and children (WIC)
Macrosomia
Haugenc,
2014 [25]
Norway 1999–2008 Prospective 56,082 Norwegian Mother and
Child cohort study
Macrosomia, caesarean section
Leed,
2014 [34]
Korea 2010–2012 Retrospective 16,297 Single medical centre LGA
Swank,
2014 [32]
USA 2007 Retrospective 1034 Californian birth certificate data Caesarean, macrosomia
Black,
2013 [23]
USA 2005–2010 Retrospective 9835 Kaiser Permanente
Southern California
LGA (provided additional outcomes
in reanalysis incl. SGA, preterm,
macrosomia and caesarean section
Kominiarekb,
2013 [18]
USA 2002–2008 Retrospective 21,020 12 institutions (19 hospitals) Caesarean section, SGA,
LGA, macrosomia
Lia, 2013 [26] China 2009–2011 Retrospective 33,973 Tianjin Women’s and
Children’s Health Centre
Caesarean, preterm delivery, LGA,
SGA macrosomia
Di Benedetto,
2012 [24]
Italy 2004–2009 Retrospective 2225 University Hospital Macrosomia, caesarean section
Moore Simas,
2012 [29]
USA 2006–2010 Retrospective 11,203 University Hospital SGA, LGA
Blomberg,
2011 [15]
Sweden 1993–2008 Retrospective 46,595 Swedish Medical birth registry Caesarean, LGA, SGA
J Parkd,
2011 [12]
Korea 2005–2007 Retrospective 2311 University Hospital SGA, LGA, macrosomia,
caesarean section, preterm birth
S Park,
2011 [27]
USA 2004–2007 Retrospective 570,672 Florida birth certificate data SGA, LGA
Vesco,
2011 [30]
USA 2000–2005 Retrospective 2080 Kaiser Permanente group practice Macrosomia, LGA, SGA
Rode, 2007 [28] Denmark 1996–1998 Prospective 2248 University Hospital Macrosomia
aData according to both Chinese and WHO BMI categories (Chinese used here)
bSample size changed when provided additional data, OR not recalculated
cSample size changed when provided additional data
dData according to both Korean and WHO BMI categories (Korean used here)
eData according to Chinese BMI categories
HAPO Hyperglycaemia and Adverse Pregnancy Outcomes, NR not reported
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For GWG above guidelines, prevalence was 51%, 51%
and 37% in the USA, Europe and Asia respectively, in-
cluding all Asian data. The proportion of women above
guidelines was different between the three regions (p <
0·0001) (using the chi-squared test). GWG above guide-
lines was higher in the USA than Asia (p < 0·0001) and
higher in Europe than Asia (p < 0·0001), but this was not
true between the USA and Europe (p = 1·0) (using the
two-sample test of proportions).
However, when Asian studies applying regional BMI cat-
egories only were analysed, GWG above guidelines (51%)
was no longer significantly different from GWG above
guidelines in the USA and Europe (p = 0.28). There was a
substantial difference between GWG below guidelines in
Asia, using regional BMI (16%), compared to WHO BMI
categories when applying IOM guidelines (60%).
A summary of pooled ORs for primary and secondary
outcomes is given in Fig. 2a and b and Table 6. Pooled
ORs for individual analyses for outcomes are presented
in Additional file 4.
Primary outcomes
SGA: eleven studies (seven USA/Europe; four Asia)
Eleven studies assessed SGA. This was defined as birth-
weight < 10th percentile for gestational age in five stud-
ies [12, 19, 26, 27, 33]; four additionally accounted for
sex [21, 23, 25, 29], one for sex and race/ethnicity [30]
and another for sex, race and parity [20].
GWG below guidelines was associated with a higher
risk for SGA than GWG within guidelines; for USA/Eur-
ope OR 1.51 (1.39–1.63), I2 = 88% and for Asia OR 1.63
(1.45–1.82), I2 = 63. The association of SGA risk was
highest with underweight women for both USA/Europe
(1.95; 1.83–2.07) and Asia (1.90; 1.34–2.70).
GWG above guidelines was associated with lower risk for
SGA than GWG within guidelines: USA/Europe (OR 0.65;
0.62–0.69) I2 = 65% and Asia (OR 0.69; 0.63–0.76) I2 = 20%.
Preterm birth: five studies (two USA/Europe; three
Asia) Five studies assessed preterm birth (< 37 weeks
gestation); four did not specify whether this was spon-
taneous or induced [16, 23, 26, 33] and one specified
spontaneous and induced combined [19].
GWG below guidelines was associated with a higher
risk for preterm birth than GWG within guidelines:
USA/Europe (OR 1.35; 1.17–1.56) I2 = 81% and Asia
(OR 1.06; 0.78–1.44) I2 = 86%.
GWG above guidelines was associated with a lower
risk for preterm birth than GWG within guidelines:
USA/Europe (0.83; 0.74–0.94) I2 = 79% and Asia (OR
0.71; 0.58–0.87) I2 = 68%.
LGA: thirteen studies (eight USA/Europe; five Asia)
Thirteen studies assessed LGA. This was defined as
birthweight > 90th percentile for gestational age in six
studies [12, 19, 26, 27, 33, 34]. Four defined LGA by
additionally accounting for infant sex [21, 23, 25, 29],
one for sex and race/ethnicity [30], one for sex, race and
parity [20] and one for sex, parity and study centre [14].
GWG below guidelines was associated with a lower
risk for LGA than GWG within guidelines: USA/Europe
(OR 0.62; 0.57–0.68) I2 = 72% and Asia (OR 0.55; 0.48–
0.63) I2 = 78%. The risk was lowest in the underweight
women: (USA/Europe [OR 0.42; 0.30–0.60] and Asia
[OR 0.42; 0.30–0.59]).
GWG above guidelines was associated with a higher
risk for LGA: USA/Europe (OR 1.93; 1.81–2.06) I2 =
Table 3 Body mass index prepregnancy by regions (%)
Region Underweight Normal weight Overweight Obese
Including all studies
USA 5 51 23 21
Europe 1 33 10 6
Asia 16 74 8 2
Excluding studies that assessed obese women [15, 18, 20, 30, 32, 35] or normal weight women only [16]
USA 5 53 24 18
Europe 3 67 21 9
Asia (overall) 17 73 8 2
Asia (regional BMI) 16 73 9 2
Asia (WHO BMI) 18 71 8 3
Table 4 Proportions of women gaining below, within and
above guidelines, stratified by prepregnancy BMI (%)
BMI group Below IOM Within IOM Above IOM
Underweight 43 36 21
Normal weight 28 36 36
Overweight 13 23 64
Obese 19 21 60
Data from 20/23 studies: n = 1,146,350 (88% of total population). Excluding
studies that did not stratify GWG by BMI category [17, 31, 36]
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80% and Asia (OR 1.68; 1.51–1.87) I2 = 69%. For both
groups, the risk was greatest in underweight women,
with risk decreasing as BMI increased.
Secondary outcomes
Macrosomia: twelve studies (seven USA/Europe; five
Asia) Macrosomia was defined as birthweight > 4000 g
in the majority [12, 17, 19–21, 23–26, 28, 31]; one study
used birthweight > 4500 g [30].
GWG below guidelines was associated with a lower
risk for macrosomia than GWG within guidelines: USA/
Europe (OR 0.62; 0.54–0.70) I2 = 39% and Asia (OR
0.60; 0.47–0.77) I2 = 79%.
GWG above guidelines was associated with a higher
risk for macrosomia: USA/Europe (OR 1.87; 1.70–2.06)
I2 = 56% and Asia (OR 2.18; 1.91–2.49) I2 = 66%. In Asia,
the risk decreased as the BMI increased.
Caesarean section: nine studies (four USA/Europe;
five Asia) Nine studies assessed caesarean section.
Seven included emergency and elective deliveries [12,
19, 23–26, 36] and two did not specify [20, 21]. Two [20,
23] included repeat caesarean (total caesarean section),
one primary caesarean only [21] and six did not distin-
guish these.
GWG below guidelines was associated with a lower
risk for caesarean: USA/Europe (OR 0.92; 0.87–0.98)
I2 = 0%, with no statistically significant result for Asia
(OR 0.98; 0.89–1.06) I2 = 83%.
GWG above guidelines was associated with a higher
risk for caesarean: USA/Europe (OR 1.26; 1.21–1.33)
I2 = 0% and Asia (OR 1.37; 1.30–1.45) I2 = 59%. In Asia,
the risk was greatest in underweight women (OR 1.51;
1.30–1.45).
Gestational diabetes: Six studies Six studies assessed
GDM, but did not use consistent definitions, and had
different findings for GWG above guidelines and GDM
risk, preventing the intended meta-analysis of GDM and
its relationship to GWG.
We were unable to demonstrate statistical significance
for comparison of ORs for SGA, preterm birth, LGA,
macrosomia and caesarean section between the USA/
Europe and Asian studies due to similar ORs and over-
lap in CIs.
Subgroup analysis: Asian studies
Of the eight studies from Asia, four were from China
[16, 26, 31, 36], two from Korea [12, 34], with one each
from Japan [19] and Taiwan [21].
Results are stratified by country in Additional files 5
and 6 (Table S2: BMI at onset of pregnancy and Table
S3: GWG during pregnancy).
Comparison between studies using ethnic-specific regional
BMI categories and WHO BMI categories
A further analysis comparing studies using regional BMI
categories (Chinese and Korean studies) and WHO BMI
categories (Japanese and Taiwanese studies) was per-
formed to assess for differences in adherence to 2009
IOM GWG guidelines and differences in maternal and
infant adverse outcomes.
Asian studies using ethnic-specific regional BMI cat-
egories showed 16% of women with GWG below guide-
lines, 33% within and 51% above, whereas studies using
WHO BMI categories had 60% with GWG below, 31%
within and 9% above (Table 5).
An additional meta-analysis was performed in Asian
studies, where studies using regional BMI categories
(Chinese and Korean studies) were compared to those
studies using WHO BMI categories (Japanese and Tai-
wanese studies) (Table 6). Pooled ORs for individual
analyses for outcomes are presented in Additional file 7.
SGA, LGA, macrosomia and caesarean section could
be examined in a meta-analysis (Table 6).
Wen et al. only included normal weight women, and
Yang et al. had women in all weight categories except
obese. Yang defined underweight as < 18 kg/m2.
For OR calculation, Hung, Xiong and Yang combined
overweight and obese into one group. The OR was used
for the overweight group here. Although Enomoto cre-
ated separate ORs for overweight and obese, only over-
weight was used in the meta-analysis as there were no
comparison groups for obese.
Table 5 Gestational weight gain during pregnancy by regions (%)
Region Below guidelines Within guidelines Above guidelines
Including all studies
USA 21 28 51
Europe 18 31 51
Asia (overall) 31 32 37
Asia (regional BMI) 16 33 51
Asia (WHO BMI) 60 31 9
Including all studies
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ba
Fig. 2 a Pooled odds ratio for individual outcomes for USA and Europe combined vs Asia, for the association between GWG below guidelines
with adverse outcomes. b Pooled odds ratio for individual outcomes for USA and Europe combined vs Asia, for the association between GWG
above guidelines with adverse outcomes
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Meta-regression
Substantial heterogeneity (I2 > 50%) was present for
GWG below guidelines for SGA (USA/Europe and Asia),
preterm birth (USA/Europe and Asia), LGA (USA/Eur-
ope and Asia), macrosomia (Asia) and caesarean section
(Asia), and for GWG above guidelines for SGA (USA/
Europe), preterm birth (USA/Europe and Asia), LGA
(USA/Europe and Asia), macrosomia (USA/Europe and
Asia) and caesarean section (Asia).
Where there was sufficient data available, we per-
formed a meta-regression analysis to investigate possible
sources of heterogeneity, including percentage of
smokers in pregnancy, mean age and percentage nulli-
parity (Additional file 8) in studies from the USA/Europe
and Asia.
The effect of GWG below guidelines on SGA (p <
0.0001) for USA/Europe was associated with mean ma-
ternal age (p < 0.0005) and nulliparity (p < 0.0005) and
marginally associated with smoking (p = 0.056). The
GWG below guidelines effect on LGA (p = 0.002) for
USA/Europe was associated with mean maternal age
(p = 0.021) and nulliparity (p < 0.005). The effect of
GWG above guidelines on LGA was significantly as-
sociated with nulliparity (p = 0.025) and marginally as-
sociated with mean age (p = 0.084) for the USA/
Europe. Heterogeneity was unexplained for the
remaining outcomes.
Publication bias
There was no evidence of publication bias for SGA, LGA,
macrosomia or caesarean section (Additional file 9).
Assessment for publication bias was not assessed for
preterm birth (less than five studies).
Risk of bias
Participants were selected from maternity clinics or from
large datasets (Additional file 10). Apart from two
studies [17, 31], there was adequate description of inclu-
sion and exclusion criteria. Studies were mostly retro-
spective, with three prospective studies [14, 25, 28] and
one unspecified [31]. Given the nature of observational
studies, attrition bias was not considered relevant. Per-
formance bias was difficult to assess. Very few studies
provided information regarding diet/exercise advice
given and whether this differed between groups. The
overweight and obese women may have been treated
more intensively, and this could be a source of bias.
However, we postulate this difference would be similar
across studies and therefore propose that studies carry a
low risk of performance bias overall.
There were three studies with moderate risk of bias
and 16 studies with low risk of bias. Main reasons for
moderate risk of bias included self-reported final weight
(detection bias), self-reported outcome measures (detec-
tion bias), failure to report all outcomes (report bias)
and insufficient adjustment for confounding variables
(confounding bias). Authors on 15 studies reported no
conflict of interest.
Discussion
In this study of 1,309,136 pregnancies, we present a sys-
tematic review, meta-analysis and meta-regression in-
corporating women from diverse ethnicities across three
continents, contemporary cohorts and from across the
BMI range. We explore ethnic differences in prepreg-
nancy BMI, prevalence of GWG outside IOM guidelines
and maternal and neonatal health outcomes between
women living in the USA, western Europe and east Asia.
Within Asia, we compare studies applying regional and
WHO BMI categories. Women in the USA and Europe
have higher prepregnancy BMI, higher prevalence of
GWG above guidelines and lower rates of GWG below
guidelines than women in Asia. However, when applying
regional BMI categories, women in Asia have similar
Table 6 Odds ratios for pregnancy outcomes by regions
Outcome USA and Europe Asia overall Regional BMI studies
(Chinese and Korean)
WHO BMI studies
(Japanese and Taiwanese)
GWG
< guidelines
GWG
> guidelines
GWG
< guidelines
GWG
> guidelines
GWG
< guidelines
GWG
> guidelines
GWG
< guidelines
GWG
> guidelines
SGA 1.51
(1.39, 1.63)
0.65
(0.62, 0.69)
1.63
(1.45, 1.82)
0.69
(0.63, 0.76)
1.43
(1.2, 1.7)
0.65
(0.57, 0.75)
1.77
(1.56, 2.01)
0.70
(0.63, 0.79)
Preterm birth 1.35
(1.17, 1.56)
0.83
(0.74, 0.94)
1.06
(0.78, 1.44)
0.71
(0.58, 0.87)
N/A N/A N/A N/A
LGA 0.62
(0.57, 0.68)
1.93
(1.81, 2.06)
0.55
(0.48, 0.63)
1.68
(1.51, 1.87)
0.61
(0.48, 0.76)
1.86
(1.66, 2.09)
0.49
(0.39, 0.62)
1.49
(1.18, 1.87)
Macrosomia 0.62
(0.54, 0.70)
1.87
(1.70, 2.06)
0.60
(0.47, 0.77)
2.18
(1.91, 2.49)
0.75
(0.68, 0.83)
2.0
(1.71, 2.34)
0.52
(0.31, 0.88)
2.76
(2.25, 3.38)
Caesarean section 0.92
(0.87, 0.98)
1.26
(1.21, 1.33)
0.98
(0.89, 1.06)
1.37
(1.30, 1.45)
0.94
(0.85, 1.04)
1.43
(1.34, 1.52)
1.02
(0.92, 1.14)
1.32
(1.19, 1.46)
N/A Unable to perform meta-analysis for preterm birth because less than 2 studies within each region
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GWG above guidelines to the other continents, but re-
tain lower prevalence of GWG below guidelines. GWG
outside guidelines is associated with adverse health out-
comes across all regions. A greater percentage of women
in Asia had GWG below guidelines, using WHO BMI
(60%) compared to regional BMI categories (16%), yet
WHO BMI was not accompanied by increased risks of
adverse outcomes.
Given that Asian women have greater risks of health
complications at a lower BMI, Asian countries often use
lower BMI cut-offs for overweight and obese categories.
However in 2004, a WHO review of relevant evidence
concluded there was no clear cut-off for overweight and
obesity for those of Asian ethnicity, and thus WHO did
not change their current BMI guidelines [37]. They
did, however, identify trigger points of > 23 kg/m2
and > 27.5 kg/m2, representing increased and high
risks respectively for public health action. In practice,
BMI categories commonly used in China [16, 26, 31]
are underweight BMI < 18.5 kg/m2, normal weight
18.5–23.9 kg/m2, overweight 24–28 kg/m2 and obese
≥28 kg/m2. In Korea, the classifications are underweight
BMI < 18.5 kg/m2, normal weight 18.5–22.9 kg/m2, over-
weight 23–25 kg/m2 and obese ≥25 kg/m2 [12, 34]. Stud-
ies from Taiwan [38, 39] and Japan used WHO BMI
categories [40] despite Japanese Society of Obesity guide-
lines that define obesity at a BMI ≥ 25 kg/m2 [41]. The
European Board and College of Obstetrics and Gynaecol-
ogy (EBCOG) [42] notes difficulties in accurately
comparing prevalence of prepregnancy BMI groups inter-
nationally with heterogeneity of data sets. However, com-
parison is important across regions to inform our
understanding of relationships between GWG and preg-
nancy outcomes. To the best of our knowledge, this is the
only systematic review comparing prepregnancy BMI and
exploring relationships to GWG and health outcomes
across international settings. We have compared Asian
studies using regional and WHO BMI categories in assess-
ment of prepregnancy BMI, GWG and pregnancy health
outcomes to explore applicability of regional and WHO
BMI categories in applying IOM GWG guidelines.
Applying WHO prepregnancy BMI categories, the
USA had the greatest prevalence of overweight and
obesity at 43%, consistent with trends from the 2013–
2014 National Health and Nutrition Examination
Survey (NHANES), with 37% of reproductive-aged
women obese [43]. This is significant as, preconcep-
tion, a higher BMI independently increases pregnancy
complications including GDM, preeclampsia, caesar-
ean section and LGA [44, 45]. In contrast, Asia had
the greatest prevalence of women in normal weight
and underweight categories. A lower BMI preconcep-
tion is associated with increased risks including SGA
[46]. The high prevalence of prepregnancy BMI outside
of the healthful range shown here highlights the crit-
ical need to focus on achieving healthy preconception
weight, especially in the USA, but also across Europe
and Asia.
Women in the USA and Europe had higher GWG
above guidelines than women in Asia. However, in stud-
ies applying ethnic-specific regional BMI categories,
women in Asia had similar rates of GWG above guide-
lines. The prevalence of GWG above guidelines is con-
sistent with observational studies [47–50]. Excess GWG
increases adverse pregnancy outcomes, independent of
BMI, as demonstrated here, and also increases postpar-
tum weight retention and obesity [45, 51]. A systematic
review of postpartum weight retention in Asian women
found that whilst prepregnancy BMI had an impact,
GWG was the most important predictor [11], supporting
the clinical relevance of our findings on long-term con-
tribution to obesity. Here we have advanced the litera-
ture to highlight the high prevalence of GWG above
guidelines across the USA, Europe and Asia and show
the impact of using regional BMI categories on the ap-
plication of IOM guidelines.
Exploring health outcomes by GWG, we combined
USA and Europe to ensure adequate numbers for
meta-analysis and compared USA/Europe to Asia.
Across regions, GWG below guidelines was associated
with a higher risk of SGA and preterm birth, compared
to GWG within guidelines. Likewise across regions,
GWG above guidelines was associated with a greater risk
for LGA, macrosomia and caesarean section. For women
in Asia, adverse outcomes were noted applying both re-
gional and WHO BMI categories. We were generally un-
able to compare differences in adverse health outcomes
because ORs between regions were similar with overlap-
ping CIs. Further research using both regional and
WHO BMI categories in all studies of GWG and health
outcomes may be useful. We also support the recom-
mendations for standardisation of GWG categories and
core outcome parameters to enable more accurate com-
parisons for future studies [42, 52].
With high prepregnancy BMI, high rates of GWG
above guidelines and clear adverse health outcomes
shown here across the USA, Europe and Asia, and in
our pooled data analysis [5], intervention is clearly vital.
The Journal of the American Medical Association edi-
torial accompanying our recent data analysis on GWG
discussed barriers to healthful lifestyle intervention dur-
ing pregnancy in addressing GWG and improving health
outcomes [53]. Barriers included inadequate evidence of
improvement of adverse pregnancy outcomes and mod-
est changes in GWG. Yet, the largest individual patient
data (IPD) analysis of 36 randomised controlled trials in
pregnancy (~ 12,000 women) [6], recently published in
The BMJ, demonstrates that even modest reduction in
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excessive GWG improves outcomes, reducing caesarean
section, preterm birth and GDM, the latter being par-
ticularly modifiable with physical activity intervention.
Reported results were independent of maternal charac-
teristics including age, BMI, parity and ethnicity, enhan-
cing generalisability of the findings. It appears that even
modest changes to lifestyle and GWG effectively reduce
adverse health outcomes, affirming the need for imple-
mentation of healthful lifestyle in routine antenatal care
for public health impact [54].
There may also be differences to consider within Asia.
Comparing Asian studies, prepregnancy BMI was simi-
lar. Overall, 16% of Chinese women were underweight,
74% normal weight and 9% overweight and obese. These
values are lower than those of recent cohort studies,
where 15–28% of reproductive-aged women in China
are above healthy weight [13, 47]. This contrasted with
Japan, with 18%, 71% and 11% respectively. In China
53% of women gained above GWG guidelines consistent
with the USA and Europe. In Japan GWG below guide-
lines was 64%, with only 7% above. These differences ar-
guably occur because WHO BMI categories were
applied in Japan. Differences may also relate to ethnic
variation. In Singapore, difference in GWG between eth-
nicities was postulated to be due to difference in diet
quality and psychosocial factors [55]. However we postu-
late that the degree of observed difference primarily re-
lated to application of BMI categories. Asian studies
have already suggested the need for specific guidelines
[56]. In 2000, Chinese-specific guidelines for GWG [57]
were developed, but have not been commonly adopted,
with most Asian studies using mainly Caucasian-derived
IOM GWG guidelines [55]. A call has been made for
multi-centre collaboration to create optimal GWG
guidelines for Asian women using modified BMI cat-
egories [58]. Here however, we demonstrate that apply-
ing regional BMI categories generated GWG patterns
and health outcomes similar to those in the USA/Eur-
ope. With regional BMI categories, apparent higher risks
of macrosomia and caesarean section were demon-
strated. Overall our data are reassuring for clinicians and
policy makers that IOM GWG guidelines are applicable
in women of Asian background, provided regional BMI
categories are used, to avoid overestimation of GWG
below recommendations that are not accompanied by
increased risks of adverse outcomes.
Limitations of our study include the lack of cohorts
from developing countries and the exclusion of
non-English language articles. It did not include studies
from eastern Europe and south Asian countries, which
have historical and ethnic differences from adjacent west-
ern European and east Asian countries respectively, yet
this is the broadest systematic review and meta-analysis
performed to date. For the meta-analysis, we combined
the USA and Europe into one group, due to inadequate
reported outcomes. Within each study there may be het-
erogeneity regarding race/ethnicity, and results should not
be interpreted that the sample represented the country of
origin. The European and Asian studies did not provide
demographic data, and we have assumed the populations
in these studies to be largely homogeneous. Studies from
the USA do include some women from Asia, and where
reported proportions are small, reporting is inconsistent,
limiting capacity to interpret the overall prevalence of
Asian women in US and European studies. Preterm birth
was not adjusted for gestational age, potentially resulting
in less total gestational weight gain than would have been
otherwise attained. Meta-analyses for GDM could not be
performed due to deficiencies in the primary data sets.
Heterogeneity among studies may affect the reliability of
the results, although this was only relevant for the effect
of GWG below guidelines in SGA and LGA in USA/Eur-
ope. Lastly, we included studies published before 2009
IOM guidelines, so treating physicians and midwives may
have had different GWG targets and guidelines compared
to studies from after that time.
Strengths are the inclusion of common maternal and
infant risks associated with GWG below and above the
IOM 2009 guidelines across the entire prepregnancy BMI
spectrum, with an analysis across three continents.
Notably, a quarter of the women in these studies were
from Asia. This is the only systematic review that has
compared Asian studies applying regional compared to
WHO BMI categories. We searched four databases, per-
formed a thorough risk of bias appraisal and sought inter-
national collaboration to facilitate reanalysis, enabling
broad inclusion of data in excess of 1.3 million pregnant
women. The collaboration with authors has enabled data
in a more homogeneous format for meta-analysis, with
unprecedented data integration and meta-analysis.
Conclusions
In this study of 1,309,136 pregnancies, incorporating
women from diverse ethnicities, contemporary cohorts
and from across the BMI range, we show that women
from the USA and Europe have higher prepregnancy
BMI than those from Asia (even when applying regional
BMI categories). In the USA and Europe, GWG above
guidelines appeared higher than in Asia and GWG
below guidelines was highest in Asia. However in Asian
studies applying regional BMI categories, GWG above
guidelines was similar across the USA, Europe and Asia.
In Asia, regional BMI categories may be more applicable
than WHO BMI categories when applying IOM GWG
guidelines. Across all prepregnancy BMI categories and
in different ethnicities, insufficient GWG is associated
with increased risk of SGA and preterm birth and excess
GWG with increased risk of LGA, macrosomia and
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caesarean section. Risks associated with excess GWG
may be higher in women from Asia. These findings have
practice and policy implications. This work attests to the
broad applicability of the 2009 IOM guidelines, when
Asian regional BMI categories are applied. As lifestyle
interventions in pregnancy increase attainment of rec-
ommended GWG and show health benefits, IOM imple-
mentation of GWG guidelines and pregnancy lifestyle
interventions should be considered broadly across ma-
ternity care [59, 60].
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